REVIEW Systematic Review of Systemic Treatments for Tinea Versicolor and Evidence-Based Dosing Regimen Recommendations

Background: Extensive or recurrent tinea versicolor (TV) can be treated with systemic antifungal therapies, but no dosing regimens have been approved for this indication. Objective: To provide evidence-based recommendations for dosing regimens. Methods: A systematic literature searchwas performed to identify trials reportingmycologic cure. All trialswere included and assessed for quality. Correlation and statistical analyses were used to evaluate the effects of different dosing regimen parameters on efficacy. Results: Fifty-seven trials investigating itraconazole, ketoconazole, fluconazole, and pramiconazole were included. Cumulative dose, treatment duration, and daily/weekly concentrations were shown to significantly influence mycologic cure rates for ketoconazole and pramiconazole but not for itraconazole and fluconazole. Conclusion: Based on the efficacy evidence and potential safety concerns, this review supports the following dosing regimens: 200 mg/d for 5 or 7 days of itraconazole, 300 mg/wk for 2 weeks of fluconazole, and 200 mg/d for 2 days of pramiconazole. Contexte: Le pityriasis versicolor étendu ou récidivant peut se traiter par des antifongiques a ̀ action générale, mais aucun régime posologique n’a éte ́ approuve ́ pour cette indication. Objectif: L’étude visait a ̀ formuler des recommandations sur la posologie, fondées sur des données probantes. Méthode: Nous avons procéde ́ a ̀ un examen méthodique de la documentation a ̀ la recherche d’essais faisant état de la guérison mycologique. Tous les essais ainsi relevés ont éte ́ inclus dans l’étude et soumis a ̀ une évaluation de la qualité. L’effet, sur l’efficacité